Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INOVIO PHARMACEUTICALS, INC.

(INO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about INOVIO PHARMACEUTICALS, INC.
2019Inovio Pharmaceuticals, Inc. Announces Strategic Organizational Restructuring; Announce..
CI
2019INOVIO PHARMACEUTICALS : Sharpens Focus On HPV-Related Diseases And Fast-to-Market Product..
PR
2019Inovio Sharpens Focus On HPV-Related Diseases and Fast-to-Market Product Candidates
CI
2019INOVIO PHARMACEUTICALS : Geneos Therapeutics Announces First Patient Dosed with its DNA-ba..
PR
2019INOVIO PHARMACEUTICALS : Completes Enrollment of VGX-3100 Phase 2 Trial for the Treatment ..
PR
2019Inovio Pharmaceuticals, Inc. Completes Enrollment of VGX-3100 Phase 2 Trial for the Tre..
CI
2019INOVIO PHARMACEUTICALS : Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the..
PR
2019Inovio Pharmaceuticals, Inc. Completes Enrollment of VGX-3100 Phase 3 Trial for the Tre..
CI
2019INOVIO PHARMACEUTICALS, INC.(NASDAQG : INO) dropped from S&P Biotechnology Select Industry..
CI
2019INOVIO PHARMACEUTICALS : Receives $8.14 Million Award to Support Further Development of it..
PR
2019Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Sk..
CI
2019MedImmune Limited Intends to Discontinue Activities with Respect to the Research Collab..
CI
2019INOVIO PHARMACEUTICALS : First to Advance Lassa Fever Candidate Vaccine Into a Clinical Tr..
PR
2019Inovio Pharmaceuticals, Inc. First to Advance Lassa Fever Candidate Vaccine into a Clin..
CI
2019Inovio and QIAGEN Establish Collaboration to Develop Diagnostic Test for VGX-3100, Inov..
CI
2019Inovio Pharmaceuticals Inc. and Plumbline Life Sciences Establish Animal Health Collabo..
CI
2019Inovio Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March..
CI
2019INOVIO PHARMACEUTICALS : Receives European Medicines Agency Certification For Quality and ..
PR
2019Inovio Pharmaceuticals, Inc. Receives European Medicines Agency Certification for Quali..
CI
2019INOVIO PHARMACEUTICALS : to Report First Quarter 2019 Financial Results on May 9, 2019
PR
2019INOVIO PHARMACEUTICALS : Publishes Cancer Killing Data of Its Transformative DNA-encoded B..
PU
2019Inovio Pharmaceuticals, Inc. Announces the Company's Novel Dna-Encoded Bi-Specific T Ce..
CI
2019INOVIO PHARMACEUTICALS : Phase 3 HPV Immunotherapy Selected As "Best Therapeutic Vaccine" ..
PR
2019INOVIO PHARMACEUTICALS : Achieves Third Cancer Indication Milestone for MEDI0457 Phase 2 D..
PR
2019Inovio Achieves Third Cancer Indication for MEDI0457 Phase 2 Development
CI
2019INOVIO PHARMACEUTICALS : Novel HPV Therapy INO-3106 Demonstrates Clinical Efficacy Against..
PU
2019Inovio Pharmaceuticals, Inc. Announces Novel HPV Therapy INO-3106 Demonstrates Clinical..
CI
2019INOVIO PHARMACEUTICALS : Presents Cancer Killing Data of Its Transformative DNA-Encoded Bi..
PU
2019Inovio Pharmaceuticals, Inc. Presents Cancer Killing Data of its Transformative DNA-Enc..
CI
2019INOVIO PHARMACEUTICALS : Completes Enrollment Ahead of Schedule In Immuno-Oncology Study f..
PU
2019Inovio Completes Enrollment Ahead of Schedule In Immuno-Oncology Study for Glioblastoma..
CI
2019INOVIO PHARMACEUTICALS : to Present at H.C. Wainwright Global Life Sciences Conference in ..
PR
2019INOVIO PHARMACEUTICALS : Appoints Global Commercial Leader to its Board of Directors
PR
2019Inovio Pharmaceuticals, Inc. Appoints Dr. Ann C. Miller to its Board of Directors
CI
2019INOVIO PHARMACEUTICALS : Ebola Vaccine Delivered Intradermally Demonstrates 100% Immunogen..
PR
2019Inovio Pharmaceuticals, Inc.'s Ebola Vaccine Delivered Intradermally Demonstrates 100% ..
CI
2019INOVIO PHARMACEUTICALS : Reports 2018 Fourth Quarter and Year-End Financial Results
PR
2019Inovio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December ..
CI
2019INOVIO PHARMACEUTICALS : Appoints Chief Operating Officer; Announces Strategic Management ..
PR
2019Inovio Pharmaceuticals, Inc. Announces Executive Changes
CI
2019INOVIO PHARMACEUTICALS : to Announce Fourth Quarter and Full Year 2018 Financial Results a..
PR
2019INOVIO PHARMACEUTICALS : Initiates REVEAL 2 Global Phase 3 Clinical Study For the Treatmen..
PR
2019Inovio Initiates REVEAL 2 Global Phase 3 Clinical Study For the Treatment of HPV-Relate..
CI
2019Inovio Pharmaceuticals, Inc. Initiates REVEAL 2 Global Phase 3 Clinical Study For the T..
CI
2019INOVIO PHARMACEUTICALS : Completes Sale of Additional Convertible Senior Notes
PR
2019INOVIO PHARMACEUTICALS : Geneos Therapeutics Secures $10.5 Million in Series A Financing t..
PR
2019Inovio Pharmaceuticals, Inc. Announces Resignation of Niranjan Y. Sardesai as Chief Ope..
CI
2019Geneos Therapeutics, Inc. announced that it has received $10.499993 million in funding ..
CI
2019INOVIO PHARMACEUTICALS : Announces First Subject Dosed with its DNA-Encoded Monoclonal Ant..
PR
2019Inovio Pharmaceuticals, Inc. Announces First Subject Dosed with Its Dna-Encoded Monoclo..
CI
2019Geneos Therapeutics, Inc. announced that it expects to receive $10.499993 million in fu..
CI
2019INOVIO PHARMACEUTICALS : Prices $65.0 Million Convertible Senior Notes Offering
PR
2019INOVIO PHARMACEUTICALS : Announces Proposed Convertible Senior Notes Offering
PR
2019Inovio Pharmaceuticals, Inc. Reports 2nd Patient Achieving Full Remission from HPV-Rela..
CI
2019INOVIO PHARMACEUTICALS : Reports 2nd Patient Achieving Full Remission from HPV-Related Hea..
PR
2019INOVIO PHARMACEUTICALS : dMAb™ PD-1 Checkpoint Inhibitors Demonstrate Higher and Mor..
PR
2019Inovio's dMAbÖ PD-1 Checkpoint Inhibitors Demonstrate Higher and More Prolonged Express..
CI
2019INOVIO PHARMACEUTICALS : DNA-Encoded Monoclonal Antibody (dMAb™) Platform Leaps Forw..
PR
2019Inovio Pharmaceuticals, Inc. Announces DNA-Encoded Monoclonal Antibody Platform Leaps F..
CI
2019INOVIO PHARMACEUTICALS : Announces Appointments to its Board of Directors
PR
2019Inovio Pharmaceuticals, Inc. Announces Board Changes
CI
2018Inovio Announces Initiation of “MD Anderson's HPV-Related Cancers Moon Shot&rdquo..
GL
2018Inovio Pharmaceuticals, Inc. Announces Initiation of HPV-Related Cancers Moon Shot Phas..
CI
2018Inovio Further Demonstrates Potency of its DNA-Encoded Monoclonal Antibody (dMAb™..
GL
2018Inovio Further Demonstrates Potency of its DNA-Encoded Monoclonal Antibody Platform in ..
CI
2018Inovio Pharmaceuticals, Inc. Announces Executive Changes
CI
2018Inovio Pharmaceuticals Reportsá2018 Third Quarter Financial Results
GL
2018Inovio Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter Ended Septe..
CI
2018Inovio HIV Vaccine PENNVAX«-GP Delivered IntradermallyáGenerated Robust, Long-Term Best..
GL
2018Inovio Pharmaceuticals, Inc. Announces HIV Vaccine PENNVAX«-Gp Delivered Intradermally ..
CI
2018Inovio Pharmaceuticals to ReportáThird Quarter 2018 Financial Results on November 8, 20..
GL
2018INOVIO PHARMACEUTICALS : Presents Progression Free Survival & PSA Doubling Time Improvemen..
PU
2018Inovio Presents Progression Free Survival & PSA Doubling Time Improvements in Prostate..
GL
2018Inovio Pharmaceuticals, Inc. Presents Progression Free Survival & PSA Doubling Time Imp..
CI
2018Inovio's DNA-Encoded Monoclonal Antibody (dMAb™) Platform Moves Ahead with Positi..
GL
Prev.1  2  3  4  5   6  7  8  9  10Next
Upcoming event on INOVIO PHARMACEUTICALS, INC.
11/10/21
Upcoming sector events